21849452|b cell|C0004561|start=11|end=17|ANAT
21849452|responses|C0871261|start=18|end=27|PHYS
21849452|neutralization|C1578828^C2987668|start=41|end=55|PROC^CONC
21849452|subset|C1515021|start=70|end=76|CONC
21849452|hiv|C0019693|start=80|end=83|DISO
21849452|small|C0700321|start=110|end=115|CONC
21849452|proportion|C1709707|start=116|end=126|CONC
21849452|hiv|C0019693|start=130|end=133|DISO
21849452|antibody|C1621287^C3665580|start=179|end=187|PHYS^ANAT
21849452|response|C2911692^C1706817^C0871261|start=194|end=202|PHYS^CONC
21849452|magnitude|C1704240^C0449286|start=218|end=227|CONC
21849452|detailed|C1522508|start=243|end=251|CONC
21849452|analysis|C1524024^C0936012^C0002778|start=252|end=260|PROC^CONC
21849452|critical|C1547298^C1511545^C1547308^C1552746^C1579038^C1551396|start=268|end=276|CONC
21849452|targeted|C0599894^C1521840|start=286|end=294|PHYS^CONC
21849452|neutralizing antibodies|C1142254|start=306|end=329|PROC
21849452|help|C1269765^C1552861|start=337|end=341|CONC
21849452|optimal|C2698651^C3260738|start=352|end=359|CONC
21849452|vaccine design|C1519889|start=372|end=386|PROC
21849452|hiv|C0019693|start=388|end=391|DISO
21849452|cross|C2828360|start=424|end=429|CONC
21849452|reactive|C0205332|start=430|end=438|CONC
21849452|serum|C0229671^C1546774^C1550100|start=439|end=444|ANAT^CONC
21849452|neutralizing antibodies|C1142254|start=445|end=468|PROC
21849452|identified|C1551388^C0205396|start=474|end=484|CONC
21849452|sera|C0229671^C3274756^C1151254^C1418531|start=497|end=501|GENE^PHYS^ANAT
21849452|panel|C1999270^C3537156^C0441833|start=541|end=546|OBJC^CONC
